Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 21(2)2020 Jan 10.
Article in English | MEDLINE | ID: mdl-31936890

ABSTRACT

Ergosterol peroxide is a natural compound of the steroid family found in many fungi, and it possesses antioxidant, anti-inflammatory, anticancer and antiviral activities. The anti-obesity activity of several edible and medicinal mushrooms has been reported, but the effect of mushroom-derived ergosterol peroxide on obesity has not been studied. Therefore, we analyzed the effect of ergosterol peroxide on the inhibition of triglyceride synthesis at protein and mRNA levels and differentiation of 3T3-L1 adipocytes. Ergosterol peroxide inhibited lipid droplet synthesis of differentiated 3T3-L1 cells, expression of peroxisome proliferator-activated receptor gamma (PPARγ) and CCAT/enhancer-binding protein alpha (C/EBPα), the major transcription factors of differentiation, and also the expression of sterol regulatory element-binding protein-1c (SREBP-1c), which promotes the activity of PPARγ, resulting in inhibition of differentiation. It further inhibited the expression of fatty acid synthase (FAS), fatty acid translocase (FAT), and acetyl-coenzyme A carboxylase (ACC), which are lipogenic factors. In addition, it inhibited the phosphorylation of mitogen-activated protein kinases (MAPKs) involved in cell proliferation and activation of early differentiation transcription factors in the mitotic clonal expansion (MCE) stage. As a result, ergosterol peroxide significantly inhibited the synthesis of triglycerides and differentiation of 3T3-L1 cells, and is, therefore, a possibile prophylactic and therapeutic agent for obesity and related metabolic diseases.


Subject(s)
Adipocytes/metabolism , Anti-Obesity Agents/pharmacology , Cell Differentiation/drug effects , Ergosterol/analogs & derivatives , Lipid Metabolism/drug effects , Reishi/chemistry , 3T3-L1 Cells/drug effects , Adipogenesis/drug effects , Adipokines , Animals , Anti-Obesity Agents/therapeutic use , CCAAT-Enhancer-Binding Protein-alpha/metabolism , Cell Survival/drug effects , Down-Regulation/drug effects , Ergosterol/chemistry , Ergosterol/pharmacology , Ergosterol/therapeutic use , Lipogenesis/drug effects , Mice , PPAR gamma/metabolism , Phosphorylation/drug effects , Sterol Regulatory Element Binding Protein 1/metabolism , Triglycerides
2.
Int J Mol Sci ; 19(8)2018 Aug 13.
Article in English | MEDLINE | ID: mdl-30104475

ABSTRACT

Next-generation sequencing (NGS) of the Flammulina elastica (wood-rotting basidiomycete) genome was performed to identify carbohydrate-active enzymes (CAZymes). The resulting assembly (31 kmer) revealed a total length of 35,045,521 bp (49.7% GC content). Using the AUGUSTUS tool, 12,536 total gene structures were predicted by ab initio gene prediction. An analysis of orthologs revealed that 6806 groups contained at least one F. elastica protein. Among the 12,536 predicted genes, F. elastica contained 24 species-specific genes, of which 17 genes were paralogous. CAZymes are divided into five classes: glycoside hydrolases (GHs), carbohydrate esterases (CEs), polysaccharide lyases (PLs), glycosyltransferases (GTs), and auxiliary activities (AA). In the present study, annotation of the predicted amino acid sequences from F. elastica genes using the dbCAN CAZyme database revealed 508 CAZymes, including 82 AAs, 218 GHs, 89 GTs, 18 PLs, 59 CEs, and 42 carbohydrate binding modules in the F. elastica genome. Although the CAZyme repertoire of F. elastica was similar to those of other fungal species, the total number of GTs in F. elastica was larger than those of other basidiomycetes. This genome information elucidates newly identified wood-degrading machinery in F. elastica, offers opportunities to better understand this fungus, and presents possibilities for more detailed studies on lignocellulosic biomass degradation that may lead to future biotechnological and industrial applications.


Subject(s)
Flammulina/genetics , Fungal Proteins/genetics , Genome, Fungal , Databases, Genetic , Flammulina/enzymology , Fungal Proteins/classification , Fungal Proteins/metabolism , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/genetics , Glycoside Hydrolases/metabolism , Glycosyltransferases/chemistry , Glycosyltransferases/genetics , Glycosyltransferases/metabolism , Phylogeny , Polysaccharide-Lyases/chemistry , Polysaccharide-Lyases/genetics , Polysaccharide-Lyases/metabolism , Sequence Analysis, DNA , Whole Genome Sequencing
3.
Int J Mol Sci ; 19(2)2018 Feb 22.
Article in English | MEDLINE | ID: mdl-29470423

ABSTRACT

Citrus fruits contain various types of flavonoids with powerful anti-aging and photoprotective effects on the skin, and have thus been attracting attention as potential, efficacious skincare agents. Here, we aimed to investigate the chemical composition of Citrus unshiu and its protective effects on photoaging. We isolated and identified a bioactive compound, 3,5,6,7,8,3',4'-heptamethoxyflavone (HMF), from C. unshiu peels using ethanol extraction and hexane fractionation. HMF inhibited collagenase activity and increased type I procollagen content in UV-induced human dermal fibroblast neonatal (HDFn) cells. HMF also suppressed the expression of matrix metalloproteinases 1 (MMP-1) and induced the expression of type I procollagen protein in UV-induced HDFn cells. Additionally, HMF inhibited ultraviolet B (UVB)-induced phosphorylation of the mitogen-activated protein kinases (MAPK) cascade signaling components-ERK, JNK, and c-Jun-which are involved in the induction of MMP-1 expression. Furthermore, HMF affected the TGF-ß/Smad signaling pathway, which is involved in the regulation of type I procollagen expression. In particular, HMF induced Smad3 protein expression and suppressed Smad7 protein expression in UV-induced HDFn cells in a dose-dependent manner. These findings suggest a role for Citrusunshiu in the preparation of skincare products in future.


Subject(s)
Citrus/chemistry , Collagen Type I/biosynthesis , Collagenases/metabolism , Dermis/cytology , Fibroblasts/metabolism , Flavonoids/pharmacology , Cell Death/drug effects , Cells, Cultured , Fibroblasts/drug effects , Flavonoids/chemistry , Humans , Infant, Newborn , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinases/metabolism , Smad3 Protein/metabolism , Smad7 Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...